Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Acth Stimulation Test

Research Leaders

6 sponsors active, led by Elza Abdessater

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Unknown2
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Acth Stimulation Test1
  • Corticosteroid Injection1
  • Cortisol1

Active Sponsors

  • Elza Abdessater1
  • Bursa Yuksek Ihtisas Training and Research Hospital1
  • Assiut University1
  • Ankara Etlik City Hospital1
  • Saglik Bilimleri Universitesi1

Top Investigators

Related Conditions

  • Adrenal Insufficiency1
  • Cardiopulmonary Arrest1
  • Reumatoid Arthritis1

Activity Timeline